{"id":"https://openalex.org/W2005121274","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","title":"Possiblein vivo5\u2010HT reuptake blocking properties of 8\u2010OH\u2010DPAT assessed by measuring hippocampal extracellular 5\u2010HT using microdialysis in rats","display_name":"Possiblein vivo5\u2010HT reuptake blocking properties of 8\u2010OH\u2010DPAT assessed by measuring hippocampal extracellular 5\u2010HT using microdialysis in rats","alternate_titles":[],"publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2005121274","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","mag":"2005121274","pmid":"https://pubmed.ncbi.nlm.nih.gov/8922730","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1915946"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1996.tb15749.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15749.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005121274"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15749.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111812553","display_name":"Marie\u2010Bernadette Assi\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marie\u2010Bernadette Assi\u00e9","raw_affiliation_strings":["Neurobiology Division II, Centre de Recherche Pierre Fabre, Castres, France","Neurobiology Division II, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology Division II, Centre de Recherche Pierre Fabre, Castres, France","institution_ids":[]},{"raw_affiliation_string":"Neurobiology Division II, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres Cedex, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080164174","display_name":"Wouter Koek","orcid":"https://orcid.org/0000-0002-9049-9719","observed_orcids":["https://orcid.org/0000-0002-9049-9719"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wouter Koek","raw_affiliation_strings":["Neurobiology Division II, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurobiology Division II, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres Cedex, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111812553"],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.7187,"has_fulltext":true,"cited_by_count":42,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.6316975,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"119","issue":"5","first_page":"845","last_page":"850"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.024000000208616257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/8-oh-dpat","display_name":"8-OH-DPAT","score":0.8840000033378601},{"id":"https://openalex.org/keywords/5-ht1a-receptor-agonist","display_name":"5-HT1A receptor agonist","score":0.8040000200271606},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibition","display_name":"serotonin reuptake inhibition","score":0.871999979019165},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.7350000143051147},{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":1.0},{"id":"https://openalex.org/keywords/flesinoxan","display_name":"flesinoxan","score":0.9670000076293945},{"id":"https://openalex.org/keywords/fenfluramine","display_name":"fenfluramine","score":0.8450000286102295},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.9810000061988831},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.3869999945163727},{"id":"https://openalex.org/keywords/synaptosomes","display_name":"synaptosomes","score":0.5960000157356262},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.718999981880188},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.7378698587417603},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.7101894021034241},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.633297324180603},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5855039358139038},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5605373978614807},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5139438509941101},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5050154328346252},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.48937124013900757},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4806743562221527},{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.46183159947395325},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.40067586302757263},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.25921863317489624},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21127867698669434},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16817614436149597},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.059064239263534546}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017371","descriptor_name":"8-Hydroxy-2-(di-n-propylamino)tetralin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1996.tb15749.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15749.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1915946","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1915946/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:8922730","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8922730","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1996.tb15749.x","doi":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1996.tb15749.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1996.tb15749.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005121274.pdf","grobid_xml":"https://content.openalex.org/works/W2005121274.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1977439893","https://openalex.org/W1986980508","https://openalex.org/W1988297901","https://openalex.org/W1990390936","https://openalex.org/W1990587716","https://openalex.org/W1998107848","https://openalex.org/W1998148889","https://openalex.org/W1999490123","https://openalex.org/W2005952501","https://openalex.org/W2009888994","https://openalex.org/W2027182831","https://openalex.org/W2034979868","https://openalex.org/W2037124232","https://openalex.org/W2046957945","https://openalex.org/W2048828371","https://openalex.org/W2055351273","https://openalex.org/W2061733755","https://openalex.org/W2066014645","https://openalex.org/W2079993704","https://openalex.org/W2084884088","https://openalex.org/W2085811848","https://openalex.org/W2086065319","https://openalex.org/W2087538846","https://openalex.org/W2093708977","https://openalex.org/W2094569992","https://openalex.org/W2135118631","https://openalex.org/W2171584675","https://openalex.org/W2223822401","https://openalex.org/W2290621392","https://openalex.org/W2909490495","https://openalex.org/W4253014749"],"related_works":["https://openalex.org/W1963819059","https://openalex.org/W2130835333","https://openalex.org/W1977886627","https://openalex.org/W1999490123","https://openalex.org/W2026493817","https://openalex.org/W2079083683","https://openalex.org/W2035416510","https://openalex.org/W2037124232","https://openalex.org/W2031542173","https://openalex.org/W1997695325"],"abstract_inverted_index":{"1.":[0],"The":[1,185],"5-hydroxytryptamine":[2],"(5-HT)1A":[3],"receptor":[4,45,177,260],"agonist,":[5],"8-hydroxy-2-(di-n-propylamino)tetralin":[6],"(8-OH-DPAT),":[7],"has":[8],"been":[9],"shown":[10],"to":[11,79],"label":[12],"5-HT":[13,35,51,61,70,123,189,231,248,272],"reuptake":[14,36,71,106,124,273],"sites.":[15],"2.":[16],"To":[17],"study":[18],"the":[19,25,34,43,57,75,81,86,143,148,165,175,227,244],"functional":[20],"consequences":[21],"of":[22,27,33,42,60,64,77,84,89,92,152,167,215,253],"this":[23],"property,":[24],"effects":[26,91,166],"8-OH-DPAT":[28,93,129,170,225,254],"were":[29,97,171],"compared":[30],"with":[31],"those":[32],"inhibitors,":[37],"paroxetine":[38,96,101,134],"and":[39,41,53,94,102,114,131,137],"clomipramine,":[40],"5-HT1A":[44,176,259],"agonist":[46,261],"flesinoxan,":[47],"in":[48,54,66,107,187,229,246,268],"vitro":[49],"on":[50,56],"reuptake,":[52],"vivo":[55],"extracellular":[58,82,150,162,188,230,247],"concentration":[59,83,151],"by":[62,95,174,191,201,207,233,250],"use":[63],"microdialysis,":[65],"rat":[67,108],"hippocampus.":[68],"Because":[69],"inhibitors":[72],"reportedly":[73],"attenuate":[74],"ability":[76],"(+)-fenfluramine":[78,196],"increase":[80,186,228,245],"5-HT,":[85],"possible":[87],"reversal":[88],"these":[90],"examined.":[98],"3.":[99],"8-OH-DPAT,":[100],"clomipramine":[103,138],"inhibited":[104],"[3H]-5-HT":[105],"hippocampal":[109,149],"synaptosomes":[110],"(pIC50:":[111],"6.00,":[112],"8.41":[113],"7.00,":[115],"respectively).":[116],"In":[117,154,211],"contrast,":[118,155],"flesinoxan":[119,156],"did":[120,159],"not":[121,160,172,199,220,256],"alter":[122,161],"(pIC50":[125],"<":[126],"5).":[127],"4.":[128],"(10":[130],"100":[132,168,208],"microM),":[133,140],"(0.1":[135],"microM)":[136,158],"(1":[139],"administered":[141],"through":[142],"dialysis":[144],"probe,":[145],"significantly":[146],"increased":[147],"5-HT.":[153,163],"(100":[157],"Moreover,":[164],"microM":[169,203,209],"blocked":[173],"antagonist,":[178],"WAY-100635":[179],"(0.16":[180],"mg":[181,193,217,222,235],"kg-1,":[182,194,218,223,236],"s.c.).":[183],"5.":[184],"induced":[190,232],"10":[192,216],"i.p.,":[195,237],"was":[197],"prevented":[198],"only":[200],"0.1":[202],"paroxetine,":[204],"but":[205,219,263],"also":[206],"8-OH-DPAT.":[210],"addition,":[212],"systemic":[213],"administration":[214,252],"2.5":[221,234],"i.p.":[224],"attenuated":[226],"(+)-fenfluramine.":[238],"6.":[239],"These":[240],"findings":[241],"suggest":[242],"that":[243],"produced":[249],"local":[251],"does":[255],"involve":[257],"its":[258,271],"properties,":[262],"may":[264],"result,":[265],"at":[266],"least":[267],"part,":[269],"from":[270],"blocking":[274],"properties.":[275]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005121274","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
